ReviewHaematologica2022
The present and future of measurable residual disease testing in acute myeloid leukemia.
James S Blachly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this papercites it
ReviewHaematologica2022
James S Blachly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.